Paper41617469
Modulating the cleavage and polyadenylation site: from research tools to therapeutic opportunities.
Ma F and 1 other. RNA, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Modulating the cleavage and polyadenylation site: from research tools to therapeutic opportunities. Papers, record 41617469. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41617469
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modulating the cleavage and polyadenylation site: from research tools to therapeutic opportunities.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Polyadenylation | Major topic |
| RNA, Messenger | Major topic |
| Humans | |
| Animals | |
| Gene Expression Regulation | |
| Poly A |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R35 GM153277 | NIGMS NIH HHS | United States | R35GM153277 | PubMed |
Source NIH RePORTER
References123
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29768209 | Influenza Virus Mounts a Two-Pronged Attack on Host RNA Polymerase II Transcription. | Cell Rep | 2018 | https://conductscience.org/library/papers/29768209 | PubMed |
| 2 | 40059188 | Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40059188 | PubMed |
| 3 | 40758869 | Harnessing BET-Bromodomain Assisted Nuclear Import for Targeted Subcellular Localization and Enhanced Efficacy of Antisense Oligonucleotides. | J Am Chem Soc | 2025 | https://conductscience.org/library/papers/40758869 | PubMed |
| 4 | 34484861 | Adenine base editing of the DUX4 polyadenylation signal for targeted genetic therapy in facioscapulohumeral muscular dystrophy. | Mol Ther Nucleic Acids | 2021 | https://conductscience.org/library/papers/34484861 | PubMed |
| 5 | 35414015 | Multiplexed genome regulation in vivo with hyper-efficient Cas12a. | Nat Cell Biol | 2022 | https://conductscience.org/library/papers/35414015 | PubMed |
| 6 | 39676659 | Direct delivery of Cas-embedded cytosine base editors as ribonucleoprotein complexes for efficient and accurate editing of clinically relevant targets. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/39676659 | PubMed |
| 7 | 30150773 | Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia. | Nature | 2018 | https://conductscience.org/library/papers/30150773 | PubMed |
| 8 | 36073787 | Fip1 is a multivalent interaction scaffold for processing factors in human mRNA 3' end biogenesis. | Elife | 2022 | https://conductscience.org/library/papers/36073787 | PubMed |
| 9 | 38087090 | The anticancer compound JTE-607 reveals hidden sequence specificity of the mRNA 3' processing machinery. | Nat Struct Mol Biol | 2023 | https://conductscience.org/library/papers/38087090 | PubMed |
| 10 | 38764173 | Programmable RNA targeting with CRISPR-Cas13. | RNA Biol | 2024 | https://conductscience.org/library/papers/38764173 | PubMed |
| 11 | 22451911 | U7 small nuclear ribonucleoprotein represses histone gene transcription in cell cycle-arrested cells. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22451911 | PubMed |
| 12 | 28988994 | Locked nucleic acid: modality, diversity, and drug discovery. | Drug Discov Today | 2018 | https://conductscience.org/library/papers/28988994 | PubMed |
| 13 | 33510937 | Designed U7 snRNAs inhibit DUX4 expression and improve FSHD-associated outcomes in DUX4 overexpressing cells and FSHD patient myotubes. | Mol Ther Nucleic Acids | 2021 | https://conductscience.org/library/papers/33510937 | PubMed |
| 14 | 23241633 | Analysis of alternative cleavage and polyadenylation by 3' region extraction and deep sequencing. | Nat Methods | 2013 | https://conductscience.org/library/papers/23241633 | PubMed |
| 15 | 17412832 | Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17412832 | PubMed |
| 16 | 31267064 | Alternative cleavage and polyadenylation in health and disease. | Nat Rev Genet | 2019 | https://conductscience.org/library/papers/31267064 | PubMed |
| 17 | 30139799 | Reconstitution of mammalian cleavage factor II involved in 3' processing of mRNA precursors. | RNA | 2018 | https://conductscience.org/library/papers/30139799 | PubMed |
| 18 | 19952748 | Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. | Curr Opin Oncol | 2010 | https://conductscience.org/library/papers/19952748 | PubMed |
| 19 | 27096365 | Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. | Nature | 2016 | https://conductscience.org/library/papers/27096365 | PubMed |
| 20 | 20133622 | Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20133622 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42170191 | Novel examples of NMD escape through alternative intronic polyadenylation. | NAR Genom Bioinform | 2026 | https://conductscience.org/library/papers/42170191 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41617469
GET https://conductscience.org/api/papers/v1/41617469/references?page=2